These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6678846)

  • 21. Fluorescein in human plasma in vitro.
    Lund-Andersen H; Krogsaa B
    Acta Ophthalmol (Copenh); 1982 Oct; 60(5):701-8. PubMed ID: 7164787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital cutaneous fluorometry: correlation between blood flow and fluorescence.
    Bongard FS; Upton RA; Elings VB; Lewis FR
    J Vasc Surg; 1984 Sep; 1(5):635-41. PubMed ID: 6502833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring tissue elimination of fluorescein with the perfusion fluorometer: a new method to assess capillary blood flow.
    Silverman DG; Cedrone FA; Hurford WE; Bering TG; LaRossa DD
    Surgery; 1981 Aug; 90(2):409-17. PubMed ID: 7256549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human corneal endothelial permeability to fluorescein and fluorescein glucuronide.
    Seto C; Araie M; Sawa M; Takase M
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1457-63. PubMed ID: 3623832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and metabolic clearance of glucose under basal conditions in Type II (non-insulin-dependent) diabetes mellitus.
    Radziuk J; Pye S
    Diabetologia; 2001 Aug; 44(8):983-91. PubMed ID: 11484075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma fluorescein decay determination during fluorophotometry.
    Boot JP; Van Best JA; Tjin a Tsoi EW; Kappelhof JP; Oosterhuis JA
    Doc Ophthalmol; 1987 Apr; 65(4):403-22. PubMed ID: 3691293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: implications for glucose monitoring.
    Smith A; Yang D; Delcher H; Eppstein J; Williams D; Wilkes S
    Diabetes Technol Ther; 1999; 1(1):21-7. PubMed ID: 11475300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in circulating iodothyronines in diabetics with various degrees of metabolic control.
    Lattanzi V; Ciampolillo A; Di Venere M; Giorgino R
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1355-61. PubMed ID: 6433942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection.
    Blair NP; Evans MA; Lesar TS; Zeimer RC
    Invest Ophthalmol Vis Sci; 1986 Jul; 27(7):1107-14. PubMed ID: 3721789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K(+)-permeability in diabetics and nondiabetics with and without renal insufficiency.
    Kraatz G; Wolf E; Gruska S
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():19-21. PubMed ID: 9288537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Sep; 59(3):371-8. PubMed ID: 6430945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma binding of fluorescein in normal subjects and in diabetic patients.
    Palestine AG; Brubaker RF
    Arch Ophthalmol; 1982 Jul; 100(7):1160-1. PubMed ID: 7092661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of fluorescein glucuronide. II. A comparative ocular kinetic study of fluorescein and fluorescein glucuronide.
    Seto C; Araie M; Takase M
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(2):113-7. PubMed ID: 3949183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.
    Waltman SR
    Trans Am Ophthalmol Soc; 1984; 82():827-49. PubMed ID: 6535330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting.
    Féry F
    J Clin Endocrinol Metab; 1994 Mar; 78(3):536-42. PubMed ID: 8126123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.